Bank of New York Mellon Corp lessened its stake in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 52.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 127,521 shares of the business services provider's stock after selling 143,442 shares during the quarter. Bank of New York Mellon Corp owned about 0.39% of Cross Country Healthcare worth $2,316,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also bought and sold shares of the company. Systematic Financial Management LP raised its position in Cross Country Healthcare by 8.5% during the third quarter. Systematic Financial Management LP now owns 1,662,730 shares of the business services provider's stock valued at $22,347,000 after purchasing an additional 130,746 shares in the last quarter. State Street Corp raised its holdings in shares of Cross Country Healthcare by 0.5% during the 3rd quarter. State Street Corp now owns 1,334,353 shares of the business services provider's stock worth $17,934,000 after buying an additional 6,582 shares in the last quarter. Jacobs Levy Equity Management Inc. bought a new stake in shares of Cross Country Healthcare during the 3rd quarter worth $7,350,000. Zweig DiMenna Associates LLC bought a new stake in shares of Cross Country Healthcare during the 4th quarter worth $6,841,000. Finally, Jane Street Group LLC boosted its stake in Cross Country Healthcare by 337.6% in the third quarter. Jane Street Group LLC now owns 181,492 shares of the business services provider's stock valued at $2,439,000 after buying an additional 140,013 shares in the last quarter. Institutional investors own 96.03% of the company's stock.
Analysts Set New Price Targets
CCRN has been the subject of several research analyst reports. William Blair downgraded shares of Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a report on Wednesday, December 4th. Barrington Research reiterated a "market perform" rating and issued a $18.61 target price on shares of Cross Country Healthcare in a research report on Friday, March 14th. Benchmark cut Cross Country Healthcare from a "strong-buy" rating to a "hold" rating in a report on Wednesday, December 4th. JMP Securities reiterated a "market perform" rating on shares of Cross Country Healthcare in a report on Thursday, February 6th. Finally, Truist Financial lifted their target price on shares of Cross Country Healthcare from $15.00 to $18.61 and gave the stock a "hold" rating in a research report on Thursday, December 5th. Six research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $18.41.
Read Our Latest Stock Report on Cross Country Healthcare
Cross Country Healthcare Trading Down 0.3 %
CCRN stock traded down $0.04 during trading on Tuesday, hitting $14.96. The company had a trading volume of 1,081,529 shares, compared to its average volume of 584,415. The stock has a market cap of $490.88 million, a PE ratio of -299.14, a PEG ratio of 3.32 and a beta of 0.44. The business has a 50-day moving average of $17.29 and a 200-day moving average of $15.19. Cross Country Healthcare, Inc. has a one year low of $9.58 and a one year high of $19.14.
About Cross Country Healthcare
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Further Reading
Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
